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The human D4 dopamine receptor has been genetically engineered for expression in insect cells using the baculovirus ystem. A D4 cDNA gene 
fusion construct [(1991) Nature 350, 610-6141 was synthetically modified to remove two introns from the coding region, and expressed in S 
frugiperda (St9) cells as a fusion with a short sequence from the polyhedrin protein. Binding assays with [3H]spiperone indicated high levels of D4 
receptor binding 90 h after infection and a pharmacological profile identical to that reported for D4 receptors expressed in COS-7 cells using the 
cDNA gene hybrid. We also show that the agonist binding affinity of D4 receptors expressed in Sf9 cells can be shifted by GTP-y-S, indicating 
coupling to G-proteins. 
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1. INTRODUCTION 
Dopamine receptors are the site of action for many 
of the drugs used currently in the treatment of schizo- 
phrenia and Parkinson’s disease. Five human dopamine 
receptors (Dl-D5) have been cloned [l-5], and all be- 
long to the family of seven transmembrane domain, 
G-protein-coupled receptors. Clozapine, a drug used in 
the treatment of schizophrenia [6], has an affinity at D4 
receptors which is significantly higher than that ob- 
served for other cloned dopamine receptors [4], suggest- 
ing that the D4 receptor may be an important therapeu- 
tic target. A preliminary pharmacological characteriza- 
tion of this receptor has been performed using monkey 
COS-7 cells transiently transfected with a D4 cDNA 
gene hybrid [4], but the use of this technique is limited 
by cell number and low levels of receptor expression. 
Therefore, an alternative expression system is required 
if sufficient receptor is to be produced for more detailed 
biochemical and pharmacological studies. 
D4 sequence we have been able to use a recombinant 
baculovirus to generate D4 receptors in Spodoptera 
frugiperda (WI) cells. Furthermore, we show that ag- 
onist binding of D4 receptors in Sfp cell membranes can 
be shifted by a GTP analogue, suggesting that the recep- 
tor is coupled to G-proteins. 
2. MATERlALS AND METHODS 
2.1. Construction of modified 04 gene vector 
The human D4 construct used for expression of the 
receptor in COS-7 cells is a cDNA genomic hybrid 
which includes two introns [4]. A number of the seven 
transmembrane receptors have been expressed at high 
levels in insect cells using the baculovirus expression 
system [7-lo], however, these receptors have all been 
derived from cDNAs. By removing the introns from the 
A 303 bp synthetic oligonucleotide fragment (Table I) was made 
from eight overlapping ohgonucleotides ynthesized on an Apphed 
Biosystems 380A DNA synthesizer. The oligonucleotides were 
phosphorylated using T4 polynucleotide kinase, mixed, and ligated 
using T4 DNA ligase [1 I]. An expression vector, pCD-PS-hD4, con- 
taining the human D4 receptor gene, was obtained from Olivier Civelli 
(Vollum Institute, Portland, OR) as a hybrid construction of genonuc 
and cDNA D4 sequences [4]. The 2.6 kbp Not1 fragment was replaced 
with the synthetic 303 bp fragment (Fig. I), and the DNA sequence 
of the insertion was confirmed by dideoxy DNA sequencing [I I]. Both 
the original hybrid D4 (pCD-PS-hD4) and modified D4 (pCD-PS- 
hD4mod) expression vectors were transiently transfected into COS- 
M6 cells [12] and membranes tested for [‘Hlspiperone bmding. 
2.2. Construction und Isolation of recombinanr buculovirus 
Correspondence address: A. Mills, Glaxo Institute for Molecular Biol- 
ogy SA, 14 chemin des Aulx, 1228 Plan-les-Ouates/Geneva, Switzer- 
land. Fax: (41) (22) 794 6965. 
The Spodopteru fruglperdu insect cell line, Sf9, was obtained from 
ATCC (Accession Number CRL 171 I). Transfer vector, pAC 373, and 
wild-type Autographa californica nuclear polyhedrosis virus 
(AcMNPV) were a gift from Max Summers (Texas A&M. College, 
TX). pAC 373 was engineered for expression with the modified D4 
cDNA as described in Fig. 2. Procedures for cell culture, co-transfec- 
tion, viral infection and purification of recombinant baculovlrus, were 
as described [l3]. 
2.3. Expressron of 04 receptors 
Abbreviations: GTP-y-S, guanosine-S-y-thiotriphosphate; MOI, mul- 
tiplicity of infection; Sf9 cells, Spodoptera frugiperdu cells. 
Sf9 cells were propagated in agitated spinners (50 rpm), of 500 ml 
to 3 litre working volume at 27”C, in TCIOO medium (Gibco, Switzer- 
land), supplemented with 10% fetal bovine serum (Seromed, Switzer- 
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Fig. 1. Modification of the D4 cDNA gene hybrid. The original D4 cDNA gene construction is a hybrid of a 3.0 kbp genomic DNA fragment 
and 0.65 kbp of cDNA [4]. The internal 2.6 kbp Not1 fragment containing the two introns, exon II and parts of exons I and III, was excised from 
pCD-PS-hD4 with NorI. A 303 bp fragment containing the D4 receptor coding regions on the 2.6 kbp Not1 fragment was synthesized and then 
inserted into the Not1 site in the pCD-PS-D4 vector. 
land). These cultures were used to inoculate a stirred tank reactor 
(Chemap, Switzerland) with 15 1 working volume. The conditions in 
the reactor were the same as for the spinners except the medium was 
supplemented with 0.1% (w/v) Pluronic F68 (BASF, Germany) and 
there was an additional control of the dissolved oxygen level at 50% 
air saturation achieved by pure oxygen sparging upon demand. A 
large virus stock (15 I) was made by infecting cells in the reactor at a 
density of 1 x lO?ml at a multiplicity of infection (MOI) of 0.1. After 
7 days, the lysate was separated from cell debris by centrifugation 
(300 x g, 15 min), stored at 4’C, and the virus titre estimated by plaque 
assay [13] to be 1 x 10s pfu/ml. This virus stock was used for all 
subsequent large-scale experiments. For receptor expression, cells 
were grown in the same conditions to a density of l-l.5 x 106/ml and 
infected at a MO1 of 10. 
Table I 
Synthetic oligonucleotides used in the construction of the modified D4 
receptor sequence 
name 
D4SEG1 
D4SEG-2 
D4SEG3 
WSEG-4 
D4SEG-5 
D4SEG-6 
D4SEG7 
LMSEG-8 
bases sequ- 
66 GGCCGCTGATCTCCTCCTCGCTCTCCTGGTACl-WCACTAl-WGTC 
TATTCAGAGGTCCAAGGTGG 
81 TG~GCTAAGCAGCCATGCGCCACCTTGGACCTCTGAATAGACGAA 
TAGTGGAAGTACCAGGAGAGCGAGGAGGAGATCAGC 
84 CGCATGGCTGCTTAGCCCACCTGTGTGATGCACTCATGGCTAT 
GGACGTCATGCTGTGTACTGCATCCATCTKAACCTATG 
91 CCACGAATCTATCTACXXTGATAGCACATAGGlTGMGATGGATGC 
AGTACACAGCATGACGTCCATAGCCATGAGTGCATCACACAGT 
CG 
79 TGCTATCAGCGTAGATAGAi-KGTGGCAGTAGCTGl-rCCTCTGCGA 
TACAACCGTCMGGTGGAAGCCGCCGTCAACTG 
77 TAGCCACGTAGCACCAATGAGCAGCAGl-D3CG5CGGClTCCACC 
l-R%CGGlTGTATCGCAGAGGAACAGCTACTG 
75 CTGCTCA~GGTGCTACGTGGCTACTGTCAGCAGCTG~TGCCGCA 
CCTGTACTGTGTGMCTCAACGACGTGCGC 
55 GGCCGCGCACGTCGlTGAGTCCACACAGTACAGGTGCGGCAACA 
GCTGCTGACAG 
These oligonucleotides comprise the synthetic 303 bp fragment corre- 
sponding to base pairs 231-533 of the human D4 coding 
sequence [4]. 
2.4. Preparation of membranes 
39 cells were harvested by centrifugation (300 x g, 10 min) 72-96 
h after infection and resuspended at approximately 3x 10’ cells/ml in 
50 mM Tris-HCl (pH 7.4), 120 mM NaCl, 5 mM KCI, 5 mM MgCI,, 
5 mM EDTA and 1.5 mM CaCl, (assay buffer) containing 0.1 mg/ml 
bacitracin, 10 &ml leupeptin and 0.1 mM PMSF. All subsequent 
operations were performed at 4°C. Following homogenization using 
an Ultra Turrax homogenizer (setting 8 for 10 s), unbroken cells and 
nuclei were pelleted at 2,000 x g for 20 min. The supematant was 
centrifuged at 48,000 x g for 30 min and the pellet resuspended at l-2 
mg protein/ml in the same buffer. Membranes could be stored at 
-80°C for 1 month without significant loss of binding activity. Prep- 
aration of COS cell membranes for binding assays was as described 
[41. 
2.5. Radioligand binding assays 
[‘H]Spiperone (Amersham, UK) binding assays were performed in 
assay buffer using 100~1 of Sf9 (10-20 pg protein) or COS-M6 mem- 
branes (25-75 pg protein) in a total volume of 500 pl. For saturation 
binding assays [‘Hlspiperone concentrations of 0.1-1.0 nM were used 
while competition assays were carried out at a concentration of 0.3 nM 
with unlabelled ligands at 10-‘*-10-4 M. Incubation was for 120 min 
at 25°C and the reaction stopped by filtration through Whatman 
GF/B filters using a Brandel cell harvester. Filters were rapidly washed 
with 3 x 4 ml of ice-cold 50 mM Tris-HCl (pH 7.4), dried and radioac- 
tivity was measured by liquid scintillation counting. Non-specific 
binding was defined as that not displaceable by 10 PM haloperidol. 
Binding data were analyzed using the computer program LIGAND 
1141. 
3. RESULTS AND DISCUSSION 
The majority of genes recombinantly expressed at 
high levels using baculovirus have been derived from 
cDNAs or intronless genomic DNAs [ 151. To facilitate 
the expression of human dopamine D4 receptors in Sf9 
cells using the baculovirus system, the introns were re- 
moved from the original D4 cDNA gene hybrid con- 
struction (Fig. 1). Additionally, the coding sequence for 
the D4 gene contains an unusually high G/C content 
131 
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Fig. 2. Structure of recombinant baculovnus transfer vector. (A) Plasmid pAC 373 BAl was derived from pAC 373 as follows: the CluI sites were 
eliminated by fill-in with the Klenow DNA polymerase and the unique EcoRV site was replaced by a unique X&I site. A 135 bp synthetic XbaILKpnl 
fragment, comprising the exact polyhedrin promotor sequence followed by polyhedrin sequences encoding the first 11 amino acids and a Cl&Kpnl 
linker sequence was used to replace the corresponding region of pAC 373 yielding plasmid, pAC 373 BAl. The modified D4 cDNA was subcloned 
into the unique site in pAC 373 BAI using synthetic CIaI linkers. (B) Sequence of the polyhedrin-D4 fusion polypeptide. 
which may pose problems for recombinant expression. 
Therefore, silent G/C base pairs were replaced in the 
synthetic sequence with A/T base pairs wherever possi- 
ble. The original hybrid construction, pCD-PS-hD4, 
and the modified construction, pCD-PS-hD4mod, were 
transfected into COS-M6 cells and tested for D4 recep- 
tor binding using [3H]spiperone. An affinity for clozap- 
ine of 30 nM was observed for both D4 expression 
constructs, indicating that the deletion of the introns 
had not altered the pharmacology of the receptor. Re- 
placement of the genomic sequence in this region did, 
however, increase D4 receptor expression in COS-M6 
cells with pCD-PS-hD4mod, giving maximal binding of 
2 pmol/mg protein compared to 0.4 pmol/mg for pCD- 
PS-hD4 (data not shown). 
The pCD-PS-hD4mod cDNA gene was then inserted 
into a recombinant baculovirus vector (Fig. 2A) such 
that the coding sequence for the first 11 amino acids of 
viral polyhedrin protein was fused to the N-terminus of 
the D4 coding sequence via a three amino acid linker 
sequence (Fig. 2B). It has been shown [16] that this 
manipulation can result in higher levels of expression of 
the heterologous protein and initial D4 constructs in 
which this sequence was omitted failed to produce any 
detectable D4 receptor binding in infected SI9 cells. 
Infection of St9 cells with recombinant polyhedrin- 
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D4 fusion baculovirus resulted in the appearance of 
saturable [3H]spiperone binding (Fig. 3A). Non-infected 
cells and cells infected with wild-type virus showed no 
specific radioligand binding. The appearance of this 
binding was time-dependent, showing a sharp rise after 
24 h and reaching a maximum of 5 pmol/mg 90-96 h 
after infection (Fig. 3B). A comparable profile of recep- 
tor expression has been observed for human /3?- 
adrenergic receptors in Sf9 cells [8]. The Kd value of 0.3 
nM for [3H]spiperone binding did not change during the 
course of expression. An examination of the affinities 
Table II 
Affimties of dopamine receptor ligands for human D4 receptor ex- 
pressed in St9 cells: comparison with COS-7 cells 
Ligand SI9 cos-7 
Clozapme 53 f 4.6 25 
Haloperidol 6.96 f 0.5 51 
Quinpirole 86 * 30 50 
Raclopride 1.367 f 133 1,621 
Spiperone 0.3 f 0.05 0.08 
Thioridazine 40 f 3 12 
YM-09151-2 0.44 * 0.07 0.1 
Data are expressed as K, values (nM) f S.E.M. from 3-8 separate 
experiments. COS-7 data are taken from [4] and [I 71. 
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of a number of dopaminergic compounds, including 
clozapine, for D4 receptors expressed in St?J cells 
showed K, values similar to those reported previously 
using D4 receptor-transfected COS-7 cells (Table II). 
The appropriate rank order of potency was maintained, 
indicating that D4 receptors in Sf9 cells display the 
characteristic pharmacology despite the presence of an 
additional 14 amino acids at the N-terminal of the re- 
ceptor. Similar N-terminal modifications of &adrener- 
gic receptors expressed in St9 cells were also without 
effect on the receptor pharmacology [181. 
Dopamine receptors in brain have been shown to 
exist in high and low affinity states for agonist binding 
[ 191. The high affinity state can be converted to low 
affinity by the addition of guanine nucleotides and is 
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Fig. 3. Expression of human dopamine D4 receptors in St9 cells 
infected with a baculovirus expression construct. Top panel, satura- 
tion binding of [‘Hlspiperone to membranes prepared from St9 cells 
expressing D4 receptors. Bottom panel, timexourse of receptor ex- 
pression. Cells were harvested before (time 0) and at 20-24 h intervals 
after infection and assayed for [3H]spiperone binding to membranes. 
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Fig. 4. Displacement of 0.3 nM [‘Hlspiperone binding by quinpirole 
in the presence (0) and absence (0) of 100 PM GTP-y-S. Each point 
is the mean of triplicates and similar results were obtained in 4 inde- 
pendent experiments. 
thought to represent receptors coupled to G-proteins 
[20]. Binding curves for quinpirole displacement of 
[3H]spiperone binding to D4 receptors expressed in St9 
cells could best be fitted [14] to a two-site model (Fig. 
4) indicating the presence of high and low affinity ag- 
onist binding sites. Addition of a non-hydrolyzable 
GTP analogue, GTP-)I-& caused a rightward shift of 
the curve (Fig. 4) where a one-site model was a better 
description of the data. This suggests that D4 receptors 
are able to couple to endogenous G-proteins in Sf9 cells. 
COS-7 cells expressing D4 receptors also showed a high 
affinity form of the receptor which was guanine nucleo- 
tide-sensitive [4]. 
In conclusion, we have used a modified cDNA coding 
for the human dopamine D4 receptor to express D4 
receptors in St9 cells which exhibit the correct pharma- 
cology and are able to couple to endogenous G-pro- 
teins. The high efficiency of receptor expression at- 
tained will allow further pharmacological and structural 
analysis of this potentially important dopamine recep- 
tor. 
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